ATYR PHARMA INC (ATYR)
US0021202025 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 11.46M | 22.54M | 9.98M | 2.34M | 16.95M | |||
| Marketable Securities | 54.53M | 75.62M | 56.16M | 105.58M | 14.74M | |||
| Receivables | 1.83M | 2.44M | 11.78M | 435.00K | 2.04M | |||
| Other Current Assets | 8.50M | 2.39M | 2.95M | 5.22M | 1.80M | |||
| Total Current Assets | 76.32M | 102.99M | 80.87M | 113.57M | 35.53M | |||
| Non-Current Assets | ||||||||
| PPE Net | 12.24M | 14.05M | 11.56M | 1.81M | 2.98M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 3.06M | 3.62M | 3.36M | 158.00K | 213.00K | |||
| Total Non-Current Assets | 15.30M | 17.66M | 14.91M | 1.97M | 3.19M | |||
| TOTAL ASSETS | 91.62M | 120.65M | 95.79M | 115.54M | 38.73M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 528.00K | 497.00K | 264.00K | N/A | 0.00 | |||
| Accrued Expenses | 9.64M | 12.39M | 10.49M | 4.98M | 4.43M | |||
| Accounts Payable | 3.95M | 3.53M | 3.11M | 1.03M | 1.43M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 14.12M | 16.42M | 13.86M | 6.01M | 5.86M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.03M | 1.43M | 1.01M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 11.33M | 12.34M | 9.63M | 398.00K | 1.38M | |||
| Total Non-Current Liabilities | 12.17M | 13.58M | 10.46M | 223.00K | 1.21M | |||
| TOTAL LIABILITIES | 26.29M | 30.00M | 24.32M | 6.24M | 7.08M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -517.08M | -468.02M | -417.63M | -372.30M | -338.53M | |||
| Additional Paid In Capital | 582.29M | 558.69M | 489.50M | 481.83M | 370.21M | |||
| Minority Interest | -186.00K | -188.00K | -180.00K | -175.00K | -166.00K | |||
| Common Shares | 76.00K | 63.00K | 29.00K | 28.00K | 11.00K | |||
| Other Shareholders' Equity | 36.00K | -74.00K | -433.00K | -263.00K | -43.00K | |||
| Shares Outstanding | 75.81M | 63.29M | 29.50M | 27.79M | 11.02M | |||
| Tangible Book Value per Share | 0.86 | 1.43 | 2.42 | 3.93 | 2.87 | |||
| Total Shareholders' Equity | 65.33M | 90.66M | 71.46M | 109.30M | 31.65M | |||
| TOTAL LIABILITIES AND EQUITY | 91.62M | 120.65M | 95.79M | 115.54M | 38.73M | |||
| Statistics | ||||||||
| Debt/Equity | 0.02 | 0.02 | 0.01 | N/A | N/A | |||
| Current Ratio | 5.41 | 6.27 | 5.83 | 18.89 | 6.06 | |||
| Return On Assets (ROA) | -69.66% | -41.76% | -47.33% | -29.23% | -41.89% | |||
| Return On Equity (ROE) | -97.69% | -55.58% | -63.44% | -30.89% | -51.26% | |||
All data in USD , ROIC based on taxRate of 0.21